Search

everythinglearnresearchcommunity

for

Search:↓

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

Finasteride safely reduces excessive hair growth in women.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

Moving horses to new places can increase their stress levels, as shown by higher stress hormone in their hair.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

The enzyme 17β-HSD type 2 mainly performs oxidation in human sebaceous glands, which may help protect against acne.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

A balanced diet and healthy lifestyle help manage PCOS symptoms.

Testosterone is important for men's sexual function, may help some women's sexual desire, while other hormones and neurotransmitters also play complex roles in sexual behavior.

Puberty often causes skin issues like acne and excessive sweating, and treatments require patience as results may vary.

Glucocorticoids are powerful anti-inflammatory drugs that must be used carefully to avoid serious side effects.

Finasteride can cause sexual problems and depression in young men.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Men with advanced liver disease and high oestrone and low testosterone levels have worse health outcomes.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Goat hair growth and follicle activity change with the seasons and differ between males and females.

Rosuvastatin improves lipid levels, reduces inflammation, but worsens insulin sensitivity in men with early-onset hair loss.

The index to ring finger ratio may indicate disease severity in female ankylosing spondylitis patients, but not in males.

The conclusion is that standardizing testosterone measurement methods is essential for better diagnosis accuracy in women.

Dutasteride makes alcohol less sedating and may lead to less drinking in men.

Women with PCOS have thicker parafoveal areas in their retinas, but their macular blood vessel density is normal.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.